Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Hsu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The American Journal of Pathology|May 10, 2008
Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysEileen Hsu, Carol A Feghali-Bostwick
Critical Reviews in Eukaryotic Gene Expression|January 17, 2008
Gene expression in pulmonary fibrosisEileen Hsu, Hidekata Yasuoka, Carol A Feghali-Bostwick
Current Rheumatology Reports|April 29, 2010
Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung diseaseKristen L Veraldi, Eileen Hsu, Carol A Feghali-Bostwick
Plos One|November 26, 2019
Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditionsSara M Garrett, Eileen Hsu, Justin M Thomas, et al.
Arthritis and Rheumatism|March 2, 2011
Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertensionEileen Hsu, Haiwen Shi, Rick M Jordan, et al.
The American Journal of Pathology|July 25, 2009
The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanismsHidekata Yasuoka, Eileen Hsu, Ximena D Ruiz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The American Journal of Pathology|May 10, 2008
Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysEileen Hsu, Carol A Feghali-Bostwick
Critical Reviews in Eukaryotic Gene Expression|January 17, 2008
Gene expression in pulmonary fibrosisEileen Hsu, Hidekata Yasuoka, Carol A Feghali-Bostwick
Current Rheumatology Reports|April 29, 2010
Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung diseaseKristen L Veraldi, Eileen Hsu, Carol A Feghali-Bostwick
Plos One|November 26, 2019
Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditionsSara M Garrett, Eileen Hsu, Justin M Thomas, et al.
Arthritis and Rheumatism|March 2, 2011
Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertensionEileen Hsu, Haiwen Shi, Rick M Jordan, et al.
The American Journal of Pathology|July 25, 2009
The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanismsHidekata Yasuoka, Eileen Hsu, Ximena D Ruiz, et al.
Pageof 1